Navigation Links
Chimerix to Present at Upcoming Investor Conferences
Date:6/2/2010

RESEARCH TRIANGLE PARK, N.C., June 2 /PRNewswire/ -- Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that Kenneth I. Moch, President and Chief Executive Officer, will present at two upcoming investor conferences:  the 9th Annual Needham Healthcare Conference, 9:00 AM ET, June 9, 2010, and the Jefferies 2010 Global Life Sciences Conference, 12:45 PM ET, June 11, 2010. The conferences are being held in New York City.

Mr. Moch will provide a corporate overview, including an update on the company's clinical-stage candidates, CMX001 and CMX157.  CMX001 is an orally-available, broad-spectrum antiviral being developed for the treatment of dsDNA viral infections in immunocompromised patients.  The compound is in Phase 1 and 2 clinical trials for the treatment of cytomegalovirus and BK virus.  CMX157, a novel lipid conjugate of the drug tenofovir, was created to improve upon the efficacy and safety of the prodrug Viread®, the leading nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV patients.  CMX157, which is in Phase 1 clinical trials, is being developed for its potential to reduce systemic toxicity and enable the development of one-pill once-a-day fixed dose anti-HIV combinations.

About Chimerix

Chimerix is developing antiviral therapeutics to treat life-threatening diseases.  Led by a world-class antiviral drug development team, Chimerix is advancing programs to address cytomegalovirus (CMV), BK virus, adenovirus, smallpox, human immunodeficiency virus (HIV), hepatitis C virus (HCV), respi
'/>"/>

SOURCE Chimerix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Chimerix Initiates Phase 1 Study of CMX157
2. Chimerix Names George Painter, Ph.D., Chairman of the Board and Chief Scientific Officer; Appoints Kenneth I. Moch President and Chief Executive Officer
3. Chimerix Names Wendy Painter, M.D., M.P.H., as Chief Medical Officer
4. Chimerix, Inc. Appoints Kenneth I. Moch Chief Operating Officer
5. Chimerix Joins International Network of Organizations to Cure Malaria
6. Chimerix Completes Phase I Study and Initiates a Phase II Multi-dose Clinical Trial for CMX001
7. Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads
8. Chimerix Appoints Neil Frazer, M.B., Ch.B., FRCA, FFPM as Chief Medical Officer
9. NeoGenomics to Present at Noble Financials 6th Annual Equity Conference on Monday, June 7th
10. China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22
11. Merrimack Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... USA (PRWEB) December 16, 2014 ... manager at Philipps- Universität Marburg’s Department of Physics, ... photonics, in the newly released SPIE Women ... never be too shy to ask questions.” , ... technology, engineering, and mathematics) occupations ranging from university ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Once more, ... provide a larger packaged waste water treatment plant to ... Abdullah Economic City (KAEC). Two years ago Bioshaft successfully ... Gate Development, serving two residential towers with an occupancy ... over a quarter million gallons per day and was ...
(Date:12/17/2014)... 17, 2014 Gene synthesis and ... has entered into a technology access and services ... apply DNA2.0’s proprietary protein engineering technology, known as ... “We are extremely excited that the global leader ... This proprietary bioengineering technology has now been validated ...
(Date:12/17/2014)... , Dec. 17, 2014  United Therapeutics Corporation (NASDAQ: ... promotions as well as changes to Martine Rothblatt ... Promotions United Therapeutics announced the promotion ... Co-Chief Executive Officer and David Zaccardelli , Pharm.D. ... connection with these promotions, Dr. Rothblatt,s title will change ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4
... Stephen Simes, chief executive,officer of BioSante Pharmaceuticals, Inc. ... featured in an exclusive interview with, http://www.wallst.net ... The interview,will be posted on http://www.wallst.net ... The interview will cover topics including BioSante,s market ...
... N.J., Sept. 24 New Brunswick,Scientific Co., Inc. ("NBS") ... the completion of the previously announced,merger transaction in which ... transaction. As a result of the merger, which was,approved ... 20, 2007,NBS, shareholders are entitled to receive $11.50 per ...
... Targets the Skin,s ... EL SEGUNDO, Calif., Sept. 24 With many ... and the,category of Internal Skincare(R), now Dr. Howard Murad, ... Inc. and author of,Wrinkle-Free Forever and The Cellulite Solution, ...
Cached Biology Technology:WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals 2New Brunswick Scientific Completes Merger Transaction with Eppendorf 2Murad Boosts Skin Immunity With the New Murad(R) Professional Line 2
(Date:12/10/2014)... 08, 2014 Research and Markets ... the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of ... rural banking and upgradation of the driver,s license ... the market. Besides the aforementioned projects, biometrics is ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:12/4/2014)... 3, 2014  Crossmatch™, a leading provider of ... DigitalPersona ® Pro Enterprise software and U.are.U ... throughout First Bank branch locations in ... and Virginia. First Bank, a progressive community ... North Carolina , selected the Crossmatch biometrics-based ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... Limited recently announced successful results in preclinical trials ... trials in humans this month to firstly test ... and later its effectiveness in treating the neuropathic ... of Melbourne's Department of Biochemistry and Molecular Biology ...
... Everyone knows that stem cells are controversial. Many people know that ... the body, from a red blood cell to a muscle cell ... cells continue to divide and renew themselves long after the point ... and the University of Washington offer one of the first clues ...
... the biggest questions in modern oceanography is how animals ... biologists at the Monterey Bay Aquarium Research Institute (MBARI) ... at least for animals that live on the deep ... hundreds of hours of deep-sea video, Bruce Robison and ...
Cached Biology News:Molecular miners find pain relief drugs from the sea 2Molecular miners find pain relief drugs from the sea 3Discovery suggests why stem cells run through stop signs 2'Sinkers' provide missing piece in deep-sea puzzle 2'Sinkers' provide missing piece in deep-sea puzzle 3'Sinkers' provide missing piece in deep-sea puzzle 4
... PATH™ Protein Microarray Slide features an ... The,PATH™ Slide is the first protein ... benefits of nitrocellulose in a thin ... signal-to-noise ratios. ,The PATH™ Slide ...
... hybridization of DNA or Protein microarrays printed ... glass slides. The proprietary design of the ... flatness, as is often the case with ... (67uL analytical cavity volume) eliminates the need ...
... Mouse monoclonal [3D12] to Lambda Free ... Mixture of light chains of human ... for independent constantly expressed epitope of ... dimer forms of free lambda chains ...
... The Sciclone ALH 4000 workstation is the ... seeking to introduce automated liquid handling capabilities,into ... that need to support routine applications on ... and,integrated for walk-away automation even when ...
Biology Products: